• Isorhamnetin and PI3K/Akt in Oocyte Maturation

  2026-09-09

  The reference study shows that isorhamnetin improves porcine oocyte maturation while reducing oxidative stress, apoptosis, mitochondrial dysfunction, and endoplasmic reticulum stress. Its main contribution is linking these protective effects to activation of the PI3K/Akt pathway, providing a mechanism-focused framework for reproductive biology experiments.

• PDHA1 Succinylation and α-KGA in Cholangiocarcinoma

  2026-09-09

  A 2025 Nature Communications study identifies PDHA1 K83 succinylation as a metabolic control point that increases alpha-ketoglutarate accumulation in the cholangiocarcinoma microenvironment. The resulting α-KGA–OXGR1–MAPK axis suppresses macrophage MHC-II antigen presentation, while pharmacologic inhibition of succinylation improves responses to gemcitabine and cisplatin in the reported experimental systems.

• Bay 11-7821: Mapping Pathogen-Driven NF-κB

  2026-09-09

  Bay 11-7821, also known as BAY 11-7082, provides a practical way to test whether pathogen-triggered monocyte inflammation depends on the NF-κB branch downstream of TLR2/TLR4. This article translates CPSIT_0844 findings into assay-design decisions while distinguishing pathway validation from receptor-level attribution.

• Naftifine HCl: Research Workflows and Troubleshooting

  2026-09-08

  Naftifine HCl combines a defined sterol-biosynthesis mechanism with flexible DMSO- and ethanol-based preparation for reproducible antifungal research. This guide translates its use into practical susceptibility, cell-compatibility, and mechanism-focused workflows while using the WNT5a/GSK3/β-catenin study as a model for orthogonal assay design.

• Topotecan for Ovarian Cancer: Evidence and Limits

  2026-09-07

  The Cochrane review by Abudou and colleagues synthesized randomized evidence on adding Topotecan to platinum–taxane chemotherapy for ovarian cancer. Its central finding was that the combination did not establish a clear survival advantage, while treatment-related toxicity remained an important consideration for clinical interpretation and future study design.

• RNA Pol II Inhibition and Active Apoptosis

  2026-09-07

  Harper et al. show that RNA Pol II inhibition kills cells through an active apoptotic response triggered by loss of hypophosphorylated RNA Pol IIA, rather than through passive depletion of transcripts and proteins. Their functional-genomic analysis defines the Pol II degradation-dependent apoptotic response and links it to mitochondrial death signaling, providing a framework for interpreting transcription-targeting anticancer drugs.

• Pheromone Signaling and Neurodegeneration in C. elegans

  2026-09-05

  Peng et al. show that pheromone exposure during the L1 developmental stage can remodel neural signaling and accelerate neurodegeneration later in adult C. elegans. The study identifies convergent ASK and ASI pathways, AIA interneuron integration, insulin-like signaling, and neuronal autophagy inhibition as components of this developmental-to-aging mechanism.

• Grazoprevir Hydrate: HCV Assay Workflows

  2026-09-04

  Build a reproducible workflow around Grazoprevir hydrate, from NS3/4A biochemical inhibition to genotype-aware cell assays. Practical dosing, controls, and troubleshooting guidance help distinguish true hepatitis C virus replication inhibition from assay artifacts.

• Caspase-3 Fluorometric Assay Kit Workflow

  2026-09-04

  Translate apoptotic signaling into quantitative DEVD-AFC fluorescence with a rapid, plate-based workflow. The assay is especially useful for separating caspase-dependent apoptosis from ferroptosis-associated stress in RSL3 models while guiding troubleshooting, normalization, and orthogonal validation.

• Cell Counting Kit-8 (CCK-8): Reliable Viability Data

  2026-09-03

  This scenario-driven guide explains how Cell Counting Kit-8 (CCK-8), SKU K1018, can improve cell viability, proliferation, and cytotoxicity workflows. It covers assay principles, controls, protocol optimization, data interpretation, and practical product-selection criteria for biomedical laboratories.

• Cyclophosphamide Workflows for Translational Research

  2026-09-03

  Cyclophosphamide supports controlled apoptosis induction in cancer cells, immune-modulation studies, and transplantation-conditioning research. This workflow-focused guide connects formulation, assay design, immune-context modeling, and troubleshooting to improve reproducibility without overstating evidence from unrelated infection models.

• Palmitic acid: Practical Protocol and QC Guide

  2026-09-02

  Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a defined saturated long-chain fatty acid input for lipid metabolism, insulin signaling, inflammation, and palmitoylation workflows. It is water-insoluble and unsuitable for aqueous-only preparation or prolonged solution storage, so solvent compatibility, prompt use, and solid-state storage must be controlled.

• Regorafenib: A Mechanistic Roadmap Beyond Kinases

  2026-09-02

  Regorafenib (BAY 73-4506) is more than a broad-spectrum kinase probe: emerging melanoma research links its activity to RRM2 suppression and ERK/E2F3 signaling. This thought-leadership analysis shows how translational researchers can connect kinase breadth, invasion biology, angiogenesis research, and tumor xenograft models into a more disciplined validation strategy.

• Rimonabant as a CB1 Assay Calibration Tool

  2026-09-01

  Rimonabant (SR141716) is more than a selective CB1 antagonist: it can serve as a pharmacological calibration tool for separating receptor-dependent effects from behavioral and formulation confounders. This article translates withdrawal-model findings into practical decisions for appetite, inflammation, and neurobiology assays.

• Zosuquidar Workflow for P-gp MDR Studies

  2026-09-01

  Build cleaner multidrug-resistance experiments with Zosuquidar (LY335979) 3HCl, from P-glycoprotein function testing to chemotherapy sensitization. This workflow combines concentration-controlled cell assays with transporter, tissue-distribution, and pharmacokinetic logic for more interpretable results.

8792 records 1/587 page Next 12345 下5页 Last page